Challenges to doing genetic association studies in transplantation

American Journal of Transplantation

Volumn 12, Issue 12, 2012, Pages 3173-3175

  Salomon, D R ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR;

BRAIN DEATH; CARDIOVASCULAR DISEASE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HEART LEFT VENTRICLE FUNCTION; HUMAN; IMMUNOHISTOCHEMISTRY; ORGAN DONOR; ORGAN TRANSPLANTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; EDITORIAL; GENOME-WIDE ASSOCIATION STUDY; HUMAN TISSUE; TRANSPLANTATION;

BRAIN DEATH; FEMALE; GRAFT SURVIVAL; HUMANS; MALE; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2; TISSUE DONORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84870477469     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2012.04267.x     Document Type: Review

References (9)

1. Khush KK, Pawlikowska L, Menza RL, et al,. Beta-adrenergic receptor polymorphisms and cardiac graft function in potential organ donors. Am J Transpl 2012; 12: 3377-3386.
2. Janssens AC, Ioannidis JP, van Duijn CM, Little J, Khoury MJ,. Strengthening the reporting of Genetic RIsk Prediction Studies: the GRIPS Statement. PLoS Medicine 2011; 8: e1000420.
3. Little J, Higgins JP, Ioannidis JP, et al,. Strengthening the reporting of genetic association studies (STREGA): An extension of the strengthening the reporting of observational studies in epidemiology (STROBE) statement. J Clin Epidemiol 2009; 62: 597-608 e4.
4. Audibert G, Charpentier C, Seguin-Devaux C, et al,. Improvement of donor myocardial function after treatment of autonomic storm during brain death. Transplantation 2006; 82: 1031-1036.
5. Heckbert SR, Hindorff LA, Edwards KL, et al,. Beta2-adrenergic receptor polymorphisms and risk of incident cardiovascular events in the elderly. Circulation 2003; 107: 2021-2024.
6. Lang SA, Maron MB, Bosso FJ, Pilati CF,. Temporal changes in left ventricular function after massive sympathetic nervous system activation. Can J Physiol Pharmacol 1994; 72: 693-700.
7. Small KM, Wagoner LE, Levin AM, Kardia SL, Liggett SB,. Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure. New England J Med 2002; 347: 1135-1142.
8. White M, Wiechmann RJ, Roden RL, et al,. Cardiac beta-adrenergic neuroeffector systems in acute myocardial dysfunction related to brain injury. Evidence for catecholamine-mediated myocardial damage. Circulation 1995; 92: 2183-2189.
9. Kathiresan S, Srivastava D,. Genetics of human cardiovascular disease. Cell 2012; 148: 1242-1257.